Related Experiment Video
Updated: Jul 10, 2025
A Modified Method for Heterotopic Mouse Heart Transplantion
Published on: June 23, 2014
50-years journey of heart transplant
Sameer Kumar1, Nikhil Tiwari1, Saurabh Singh2
1Consultant (Surgery) & CT Surgeon, Army Institute of Cardio Thoracic Sciences (AICTS), Pune, India.
Insights
Heart transplantation has advanced significantly over 50 years, improving outcomes for end-stage heart disease. Donor shortages remain a challenge, with ventricular assist devices offering crucial support.
Area of Science:
- Cardiology
- Transplantation Medicine
- Immunology
Background:
- Heart transplantation is a vital treatment for end-stage heart failure unresponsive to other therapies.
- Significant advancements in immunosuppression and standardized protocols have enhanced cardiac transplant outcomes over five decades.
- Limited donor organ availability restricts the number of heart transplants performed globally.
Purpose of the Study:
- To review the current status of heart transplantation 50 years after its inception.
- To discuss the evolution of immunosuppression and its impact on transplant success.
- To examine challenges and specific considerations for heart transplantation within the country.
Main Methods:
- This is a review article, synthesizing existing literature and data.
- Analysis of historical trends in heart transplant procedures and outcomes.
- Discussion of the role and development of left ventricular assist devices (LVADs).
Main Results:
- Cardiac transplant outcomes have markedly improved due to advances in immunosuppressive therapy and protocol standardization.
- Left ventricular assist devices (LVADs) have become essential, serving as bridges to transplant or as destination therapy.
- Donor organ scarcity continues to be the primary limitation for heart transplantation worldwide.
Conclusions:
- Heart transplantation remains a critical intervention for advanced heart failure, with outcomes significantly improved over 50 years.
- The development and application of ventricular assist devices have expanded treatment options for patients awaiting transplants.
- Addressing donor availability and country-specific issues are crucial for the future of heart transplantation.
Abstract:
Heart transplant is an established modality for the treatment of heart disease refractory to medical therapy. The last 50 years have seen the evolution of immune suppression therapy and standardization of protocols which have significantly improved outcomes following cardiac transplants. Donor availability is the main limiting factor and has restricted the number of heart transplants worldwide. Simultaneously, left ventricular assist devices have evolved to provide a "bridge" for recovery and transplant and alternatively as destination therapy to those waiting for the availability of a donor. This review article provides an overview of the current status of heart transplants after half a century and specific issues pertaining to our country.
